SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: makingbiigdough, steez
Search This Board: 
Last Post: 3/22/2017 6:43:34 PM - Followers: 193 - Board type: Free - Posts Today: 0

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.

 

CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.

 
ADJUVANT PIPELINE:

 

 
CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243

 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
NVAX News: Statement of Changes in Beneficial Ownership (4) 03/20/2017 04:20:17 PM
NVAX News: Statement of Changes in Beneficial Ownership (4) 03/20/2017 04:18:43 PM
NVAX News: Statement of Changes in Beneficial Ownership (4) 03/20/2017 04:18:03 PM
NVAX News: Statement of Changes in Beneficial Ownership (4) 03/20/2017 04:16:22 PM
NVAX News: Statement of Changes in Beneficial Ownership (4) 03/20/2017 04:15:01 PM
PostSubject
#4001   Gap filled. eom wickw50 03/22/17 06:43:34 PM
#4000   I grabbed a few more $1.24's bleu22 03/22/17 12:28:32 PM
#3999   RSI = 33.78 ... Hovering just above Over-sold territory. wickw50 03/22/17 07:49:26 AM
#3998   Gap up at the bell? Who knows. eom wickw50 03/21/17 11:02:15 PM
#3997   Added some more today... eom wickw50 03/21/17 05:56:15 PM
#3996   Picked up a starter here today. Ichauway 03/21/17 05:35:23 PM
#3995   Biotech getting crushed today, idk why bleu22 03/21/17 03:49:13 PM
#3994   Gup80 I'm lookin for pure sunshine. Lol .. Dgoff 03/21/17 03:37:52 PM
#3993   Dark forces at play. Gup80 03/21/17 03:29:08 PM
#3992   Price still dropping with high volume. Phenomenal Dgoff 03/21/17 02:08:11 PM
#3991   NVAX 370 market cap GOVX 3.5 market cap 3DYOGI 03/21/17 07:07:25 AM
#3990   FOR SURE bleu22 03/20/17 06:55:15 PM
#3989   Bleu22, That ought to give Jim an incentive wickw50 03/20/17 06:52:50 PM
#3988   Statement of Changes in Beneficial Ownership (4) Source: Edgar bleu22 03/20/17 05:39:11 PM
#3987   Need more definitive information from NVAX. This is Dgoff 03/20/17 02:29:20 PM
#3986   GOVX deepest pipeline 50 million shares 37 floating 3DYOGI 03/19/17 08:10:14 AM
#3985   They still are 90 MILLION bleu22 03/18/17 06:54:37 PM
#3984   B22, When did gates add more? eom wickw50 03/17/17 09:20:20 PM
#3983   BIG BILL, is still putting $$ here, good bleu22 03/17/17 02:56:26 PM
#3982   This needs an update from management on the wickw50 03/17/17 01:13:53 PM
#3981   LONG 3DYOGI 03/16/17 03:58:28 PM
#3980   https://www.google.com/amp/seekingalpha.com/amp/news/3170673-genocea-bios-genita bleu22 03/15/17 12:16:31 PM
#3979   https://www.google.com/amp/s/www.zacks.com/amp/stock/news/149738/genocea-up-on-p bleu22 03/15/17 12:14:30 PM
#3978   Pretty much the same here. Could be a Gup80 03/15/17 12:00:18 PM
#3977   Ty wick Dgoff 03/13/17 11:39:58 AM
#3976   The dosage in the trial apparently wasn't sufficient wickw50 03/13/17 11:21:46 AM
#3975   Why the big drop Dgoff 03/13/17 10:02:57 AM
#3974   PATIENCE IS THE KEY FOR THOSE PLAY WE steez 03/10/17 11:15:02 PM
#3973   bleu22, If NVAX can beat the giant Takeda wickw50 03/07/17 09:03:51 PM
#3972   I'm holding 1.20's and 1.30's, I will wait, bleu22 03/07/17 08:06:51 PM
#3971   Sorry dude wrong board lol stockwinner 03/07/17 12:10:00 PM
#3970   And when will that be Have gene gone stockwinner 03/07/17 12:09:34 PM
#3969   stockwinner, ....... Unless Novavax gets an interim from wickw50 03/06/17 11:44:11 PM
#3968   NVAX is a dead money for now hold stockwinner 03/06/17 04:14:40 PM
#3967   Bird flu? stockhabit 03/06/17 09:55:27 AM
#3966   I read the most recent news. Having been Bx3 03/03/17 01:53:51 AM
#3963   * * $NVAX Video Chart 02-28-17 * * ClayTrader 02/28/17 05:20:21 PM
#3962   IBB about to break 52-week high, and biotechs bleu22 02/28/17 11:57:01 AM
#3961   Looks like this may go positive by the EoD. Sinjin LaGrange 02/28/17 09:54:15 AM
#3960   Bought more premarket at 1.47 Santo 02/28/17 09:49:46 AM
#3959   Nice buys going through bleu22 02/28/17 09:44:59 AM
#3958   still think we are a little early. This tiv111 02/27/17 04:46:36 PM
#3957   They are still losing money but not has Sinjin LaGrange 02/27/17 04:22:17 PM
#3956   Earning look good, plus grant from bill and bleu22 02/27/17 04:17:21 PM
#3955   BIG BOYS DEFINITELY BUYING.. bleu22 02/27/17 03:57:59 PM
#3954   Maybe they have something up there sleeves after Santo 02/27/17 03:57:54 PM
#3953   Would be nice to close HOD or above. bleu22 02/27/17 03:56:34 PM
#3952   Something is cooking! Santo 02/27/17 03:10:39 PM
#3951   IBB close to 52-week high bleu22 02/27/17 02:59:33 PM
#3950   When we do 63-million shorties to squeeze. bleu22 02/27/17 01:08:30 PM
PostSubject